# Ne oldu?

The U.S. Food and Drug Administration (FDA) has issued an early alert concerning Abiomed's Automated Impella Controllers (AIC) and Optical Controllers. The agency identified a potentially high-risk issue involving purge cassette component failures. This communication serves as a safety notice to healthcare providers and institutions using these cardiac support devices.

# Ayrıntılar

According to the FDA early alert, the purge cassette components within the Automated Impella Controllers may fail, leading to device alarms and potential operational failures. The alert specifies that all AIC units globally are in scope for removal from use while awaiting service from Abiomed. A phased removal approach is being implemented.

The document emphasizes that improper cleaning of the AIC housing can cause damage to plastic components, including the purge flag. In the event of purge flag component failures and associated alarms, the recommended immediate action is to reinsert the purge disc. If that action does not clear the alarm, clinicians are advised to switch to a backup Automated Impella Controller.

# Neden önemli?

This alert is significant because the affected devices are used in critical care settings to support heart function. Device failures in this context can have serious clinical consequences. The requirement for global removal while awaiting service could impact hospital inventory and continuity of cardiac care. The guidance provides specific, actionable steps for clinicians to manage alarms, which is essential for patient safety during procedures.

# Arka plan

Abiomed's Impella devices are minimally invasive heart pumps used to support cardiac function in patients with severe heart failure or during high-risk percutaneous coronary interventions. The Automated Impella Controller is the device management system that operates the pump. This early alert stems from quality or design concerns related to the purge cassette mechanism, which is integral to the device's function. The FDA typically issues such alerts when a safety issue is identified that requires immediate attention but may not yet rise to the level of a formal recall, though the directive for global removal suggests a serious concern.

# Sırada ne var?

Hospitals and clinics currently using Abiomed Automated Impella Controllers should inventory their devices and verify status. While awaiting replacement units from Abiomed, existing hospital inventory can be used to ensure continuity of care. Healthcare providers should remain vigilant for purge flag alarms and follow the recommended troubleshooting steps: reinserting the purge disc or switching to a backup controller. Further communications from Abiomed and the FDA are expected as the phased removal process unfolds and replacement units become available.